Corporate Governance25 Sept 2026, 04:22 pm
Akums Drugs Trading Window Closed for Q2 FY27 Results
AI Summary
Akums Drugs and Pharmaceuticals Ltd has announced the closure of its trading window for designated persons and their immediate relatives. The window will be shut from October 1st, 2026, until 48 hours after the declaration of the un-audited standalone and consolidated financial results for the quarter ending September 30th, 2026. The company will announce the date of the board meeting to approve these results in due course. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Key Highlights
- Trading window closed from October 1st, 2026.
- Closure is for designated persons and immediate relatives.
- Period covers Q2 FY27 financial results announcement.
- Compliance with SEBI Insider Trading Regulations.
- Board meeting date for results approval to be announced.
Price Impact
More from AKUMS